Cancelling your registration will remove your access to the event. If you proceed, you will no longer be able to participate or access event-related materials.
Deleting your account will remove your access to the event.
Are you sure you want to change your ticket selection ?
Protecting your privacy is very important to us. This privacy policy describes what information we collect, why we collect it, and what we do with it. This privacy notice covers CMS.gov, marketplace.cms.gov, innovation.cms.gov, partnershipforpatients.cms.gov, and hfpp.cms.gov. These websites are referred to as “CMS.gov” throughout the rest of this notice and are maintained and operated by the Centers for Medicare & Medicaid Services (CMS). The privacy notice for other CMS websites not listed above is available at https://www.cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html.
CMS.gov doesn’t collect name, contact information, or other similar information through these websites unless you choose to provide it. We do collect other, limited, non-personally identifiable information automatically from visitors who read, browse, and/or download information from our website. We do this so we can understand how the website is being used and how we can make it more helpful. For more information, see Types of information we collect.
Personally identifiable information (PII), defined by the Office of Management and Budget (OMB), refers to information that can be used to distinguish or trace an individual's identity, like their name, Medicare Number, biometric records, etc. alone, or when combined with other personal or identifying information which is linked or linkable to a specific individual, like date and place of birth, mother’s maiden name, etc. Medicare Fee-for-Service eligibility and enrollment information and claims data are considered protected health information (PHI) under the Health Insurance Portability and Accountability Act (1996) (HIPAA) regulations.
We don’t sell any information you provide when you visit CMS.gov. For information on how we share information, see How CMS uses information collected on CMS.gov.
We believe our community should be truly open to everyone. As such, we are committed to providing a friendly, safe
and welcoming environment for all, regardless of gender, sexual orientation, disability, ethnicity, or religion.
This code of conduct outlines our expectations for participant behavior, as well as the consequences for
unacceptable behavior.
We invite all sponsors, speakers, attendees, media, exhibitors, and other participants to help us realize a safe and
positive conference experience for everyone.
All determinations of appropriate or inappropriate behavior are at Informa’s sole discretion, and the
decision(s) of the Informa representatives on-site will be final.
• Be considerate, respectful, and collaborative.
• Refrain from demeaning, discriminatory, or harassing behavior, materials and speech.
• Be mindful of your surroundings and of your fellow participants. Alert conference organizers if you notice a
dangerous situation or someone in distress.
• Unacceptable behaviors and materials include intimidating, harassing, abusive, discriminatory, derogatory, or
demeaning materials or conduct by any attendees of the event and related event activities. Many event venues are
shared with members of the public; please be respectful to all patrons of these locations.
• Harassment includes offensive comments (verbal, written, or otherwise) related to gender, sexual orientation,
race, religion, or disability; inappropriate use of nudity and/or sexual images in public spaces (including
presentation slides); deliberate intimidation, stalking or following; harassing materials, photography or recording;
sustained disruption of talks or other events (whether verbal or otherwise); inappropriate physical contact, and
unwelcome sexual attention.
• Wearing clothing that is not suitable for a professional work environment, that is provocative, or otherwise
potentially offensive.
• Physical, written, verbal or other abuse, intimidation, threats, annoyance, harassment, stalking, pushing,
shoving or use of any physical force whatsoever against any person, which in any way creates a disturbance that is
disruptive or dangerous, or creates apprehension in a person, as determined by Informa and its show management, in
their sole discretion.
• Possession of any item that can be used as a weapon, which may cause danger to others if used in a certain
manner.
• Any boisterous, lewd or offensive behavior or language, including but not limited to using sexually explicit
or offensive language, materials or conduct, or any language, behavior or content that contains profanity, obscene
gestures, or racial, religious or ethnic slurs,
• Possessing any open can, bottle or other receptacle containing any alcoholic beverages, except in areas
specifically designated for the consumption of alcohol. Please drink responsibly.
• Possessing any illegal substance, including but not limited to narcotics, marijuana, or other illegal drugs.
Informa does not tolerate the use or abuse of illegal substances anywhere in the Venue.
• Smoking – other than in designated areas.
• Assembling for the purpose of, or resulting in, disturbing the peace, or committing any unlawful act or
engaging in any offensive behavior.
• Failure to obey any rules or regulations of the Venue.
Unacceptable behavior will not be tolerated whether by other attendees, media, speakers, volunteers, organizers,
venue staff, sponsors, or exhibitors. Anyone asked to stop unacceptable behavior is expected to comply immediately.
If a participant engages in unacceptable behavior, the conference organizers may take any action they deem
appropriate, up to and including expulsion from the conference without warning.
If you are subjected to unacceptable behavior, notice that someone else is being subjected to unacceptable behavior,
or have any other concerns, please notify a conference organizer as soon as possible. All reports will remain
completely confidential.
Event Staff will be available to help participants contact venue security or local law enforcement, to provide
escorts, or to otherwise assist those experiencing unacceptable behavior to feel safe for the duration of the
conference. You can report unacceptable behavior to any member of staff. Staff can be found in the Show
Office onsite or you may email one of the contacts below.
We expect all conference participants (staff, sponsors, volunteers, speakers, attendees, and other guests) to abide
by this code of conduct at all conference venues and conference-related social events.
Video recordings and photographs are being taken at this event. By entering you agree to have your image and likeness used by the Centers for Medicare & Medicaid Services and Rainmakers Strategic Solutions LLC.
Dr. Marty Makary was confirmed by the United States Senate on March 25, 2025 in a bipartisan vote to be the 27th Commissioner of the FDA. He previously worked as a surgical oncologist as a researcher, professor and chief of Islet Transplant Surgery at the Johns Hopkins University School of Medicine, where he also served jointly on the faculty of the School of Public Health and Business Schools. He has published more than 350 scientific peer-reviewed articles and three New York Times bestselling books, including most recently, “Blind Spots”. He is the recipient of the Nobility in Science award from the National Pancreas Foundation and has been elected the National Academy of Medicine.
Jay Bhattacharya, M.D., Ph.D., is the 18th Director of the National Institutes of Health. A physician, researcher, and health economist, he previously served as a tenured professor at Stanford University. His work focuses on aging, chronic disease, and vulnerable populations, and he has authored more than 170 peer‑reviewed publications.
John Brooks is Deputy Administrator and Chief Policy and Regulatory Officer for CMS. He previously founded South Capitol, a health policy consulting firm. John held senior roles including Senior Advisor for Drug Pricing Reform at HHS, Principal Deputy Director at CMS, and Health Policy Advisor at the White House. He led the Health Policy Department at MITRE Corporation and holds a JD from UVA and an MBA from Virginia Tech.
Kimberly Brandt is CMS’s Deputy Administrator and Chief Operating Officer. Previously, she was a Partner at the Washington, D.C.-based policy firm Tarplin, Downs & Young, LLC, where she provided strategic advice on a broad array of healthcare regulatory, enforcement, and policy matters. She also served as an Advisor to the private equity firm Enhanced Healthcare Partners, a private equity firm focused on healthcare and held board positions at two of its portfolio companies.
Chris Klomp is the Director of Medicare, Deputy Administrator of CMS, and Senior Advisor to HHS Secretary Kennedy. He built Collective Medical, co-founded, advised, and served on the board of many innovative startups and on the Utah Digital Health Services Commission, and worked at Bain Capital and Bain & Company. Chris holds a B.A. with honors in Economics and English from BYU and an MBA from Stanford. He lives in Washington, DC, and Park City, UT, with his wife and four children.
Abe Sutton serves as the Director of the Center for Medicare and Medicaid Innovation and Deputy Administrator for the Centers for Medicare and Medicaid Services (CMS). Before assuming this role, he was a Principal at Rubicon Founders where he co-founded two health service companies; Honest Health and Evergreen Nephrology. Sutton focused on health policy with the federal government from 2017 to 2019, serving at the National Economic Council, Domestic Policy Council and Health and Human Services
Dora Hughes, M.D., M.P.H., is Chief Medical Officer and Director of the Center for Clinical Standards and Quality at CMS, leading national efforts to improve quality, safety, and outcomes for Medicare beneficiaries. She previously served as CMO at the CMS Innovation Center and held senior roles at HHS, the U.S. Senate, and in academia and industry. Dr. Hughes holds degrees from Washington University, Vanderbilt, and Harvard.
Stephanie Carlton serves as Deputy Administrator and Chief of Staff at CMS and previously served as Acting Administrator, leading the Agency during a period of transition. Her experience spans health care policy, delivery, and system reform, including senior leadership roles at McKinsey & Company and on the U.S. Senate Finance Committee, as well as clinical experience as a labor and delivery nurse, with a focus on Medicare, Medicaid, quality, and performance across the U.S. health care system.
Dan is the Director of Medicaid and CHIP and Deputy Administrator at CMS, with extensive experience in health care technology, reform, and care delivery models, advancing cross-sector coordination, data interoperability, and analytical insights. Previously, Dan was the CEO and Co-Founder of Unite Us, the nation’s largest outcome focused technology infrastructure that connects health care, government, and community-based services to coordinate care in real-time for millions of Americans.
Hardeep Singh MD MPH is a research leader focused on improving patient safety and reducing diagnostic errors. His work has informed numerous national and international initiatives, policy reports, and resources (including ONC SAFER Guides, Safer Dx Checklist, Measure Dx, & Calibrate Dx) to advance patient safety. He received the 2021 Eisenberg Award for lifetime achievement and, in Spring 2026, will be the inaugural Director of the Safety, Quality, and Well-Being Institute at Houston Methodist.
Dr. Volpp is Director of Penn’s Center for Health Incentives and Behavioral Economics, the Mark V. Pauly President’s Distinguished Professor at Penn’s Perelman School of Medicine and the Wharton School, and Scientific Lead of AHA’s Health Care by Food Initiative, building evidence on food is medicine. Dr. Volpp has contributed to benefit designs using financial incentives, redesigns of primary care payment, the “Humana Simplicity” health plan, and ‘enhanced active choice’ used by CVS members.
As Microsoft’s Global CMO, David has led efforts around COVID-19 (working with WHO, CDC, and U.S. States), responsible AI (as co-founder of Trustworthy Responsible AI Network [TRAIN], and rural health (as co-founder of Rural Health Transformation Collaborative). He has pioneered the development of evidence-based order sets in EHRs and home-based cardiac rehab. He holds 6 U.S. technology patents that enable authoring, mapping, and integration of CDS into EHRs. He is Adjunct Professor at Stanford.
Tony Robbins is a #1 New York Times bestselling author, entrepreneur, and philanthropist with nearly five decades of impact. His book Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love focuses on advances in precision medicine and innovative health technologies to maximize energy, prevent disease, and extend lifespan. The Tony Robbins Foundation supports health and human services programs through awarding over 2,500 grants, gathering thousands of young leaders around the world. Driven by his commitment to ending hunger and in partnership with Feeding America and the 100 Billion Meals Challenge, Mr. Robbins has helped deliver 62 billion meals to address food insecurity.
Jeneen Iwugo serves as the Acting Director of CMS’ Center for Program Integrity, bringing over 20 years of government leadership experience. She directs enterprise-wide enforcement operations including Risk Adjustment Data Validation audits, agent and broker fraud elimination in Marketplace exchanges, and she oversees provider enrollment, investigative activities, and the revocation process. In 2025, she delivered landmark results—preventing $5 billion in fraudulent claims and revoking over 5,000 providers. She holds an MPA from the University of Baltimore and a BS from Temple University.
Rita K. Jew, Pharm.D., MBA, BCPPS, FASHP is President at the Institute for Safe Medication Practice (ISMP), Willow Grove, Pennsylvania. Prior to ISMP, Dr. Jew held various leadership positions including Director of Pharmacy at UCSF Health, Executive Director of Pharmacy & Clinical Nutrition Services at CHOC Children’s, and Clinical Manager at Children’s Hospital of Philadelphia. Her 25 plus-year tenure in hospital pharmacies includes broad experiences in pharmacy and clinical leadership.
